Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Receivables - Net (2016 - 2025)

Marimed (MRMD) has disclosed Receivables - Net for 14 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net rose 8.66% to $8.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.0 million, a 8.66% increase, with the full-year FY2024 number at $8.7 million, up 21.43% from a year prior.
  • Receivables - Net was $8.0 million for Q3 2025 at Marimed, up from $7.7 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $9.2 million in Q1 2025 to a low of $1.7 million in Q4 2021.
  • A 5-year average of $6.8 million and a median of $7.3 million in 2024 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: crashed 75.04% in 2021, then soared 425.81% in 2022.
  • Marimed's Receivables - Net stood at $1.7 million in 2021, then skyrocketed by 425.81% to $8.8 million in 2022, then dropped by 17.82% to $7.2 million in 2023, then increased by 21.43% to $8.7 million in 2024, then dropped by 9.0% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Receivables - Net are $8.0 million (Q3 2025), $7.7 million (Q2 2025), and $9.2 million (Q1 2025).